Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital

In a regional oncology hospital using cotrimoxazole (trimethoprim-sulphamethoxazole) prophylaxis during chemotherapy-induced neutropenia, a single strain of Escherichia coli (indole negative) caused 15 of 27 episodes of Gram-negative rod bacteremia in 1987, and four of 32 such episodes in 1988. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel B Gregson, Anne G Matlow, Andrew E Simor, Peter G Tuffnell, Donald E Low, Ronald Feld, James E Brunton
Format: Article
Language:English
Published: Wiley 1992-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1992/140845
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565018527268864
author Daniel B Gregson
Anne G Matlow
Andrew E Simor
Peter G Tuffnell
Donald E Low
Ronald Feld
James E Brunton
author_facet Daniel B Gregson
Anne G Matlow
Andrew E Simor
Peter G Tuffnell
Donald E Low
Ronald Feld
James E Brunton
author_sort Daniel B Gregson
collection DOAJ
description In a regional oncology hospital using cotrimoxazole (trimethoprim-sulphamethoxazole) prophylaxis during chemotherapy-induced neutropenia, a single strain of Escherichia coli (indole negative) caused 15 of 27 episodes of Gram-negative rod bacteremia in 1987, and four of 32 such episodes in 1988. This biotype had not been recovered in 1986. Investigations during this ‘outbreak’ of bacteremias revealed enteric colonization with this strain of E coli in 37% of patients on leukemia or bone marrow transplant wards and in several staff members in July 1987. In 1988, 11 of 32 Gram-negative rod bacteremias were secondary to other strains of indole positive E coli of several different biotypes and plasmid profiles. Indole negative strains all exhibited low level trimethoprim resistance, whereas indole positive strains which subsequently appeared exhibited high level trimethoprim resistance. Failure of cotrimoxazole prophylaxis was initially due to the clonal dissemination of a single strain of E coli within the institution, with the subsequent appearance of multiple E coli strains with probable differing genetic bases for their resistance.
format Article
id doaj-art-53576c19e0a74608a76e79642961aefc
institution Kabale University
issn 1180-2332
language English
publishDate 1992-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases
spelling doaj-art-53576c19e0a74608a76e79642961aefc2025-02-03T01:09:31ZengWileyCanadian Journal of Infectious Diseases1180-23321992-01-0131141810.1155/1992/140845Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology HospitalDaniel B Gregson0Anne G Matlow1Andrew E Simor2Peter G Tuffnell3Donald E Low4Ronald Feld5James E Brunton6Departments of Medicine and Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, CanadaDepartments of Medicine and Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, CanadaDepartments of Medicine and Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada Princess Margaret Hospital, University of Toronto, Toronto, Ontario, CanadaDepartments of Medicine and Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, CanadaDepartments of Medicine and Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, CanadaUniversity of Toronto, Toronto, Ontario, CanadaIn a regional oncology hospital using cotrimoxazole (trimethoprim-sulphamethoxazole) prophylaxis during chemotherapy-induced neutropenia, a single strain of Escherichia coli (indole negative) caused 15 of 27 episodes of Gram-negative rod bacteremia in 1987, and four of 32 such episodes in 1988. This biotype had not been recovered in 1986. Investigations during this ‘outbreak’ of bacteremias revealed enteric colonization with this strain of E coli in 37% of patients on leukemia or bone marrow transplant wards and in several staff members in July 1987. In 1988, 11 of 32 Gram-negative rod bacteremias were secondary to other strains of indole positive E coli of several different biotypes and plasmid profiles. Indole negative strains all exhibited low level trimethoprim resistance, whereas indole positive strains which subsequently appeared exhibited high level trimethoprim resistance. Failure of cotrimoxazole prophylaxis was initially due to the clonal dissemination of a single strain of E coli within the institution, with the subsequent appearance of multiple E coli strains with probable differing genetic bases for their resistance.http://dx.doi.org/10.1155/1992/140845
spellingShingle Daniel B Gregson
Anne G Matlow
Andrew E Simor
Peter G Tuffnell
Donald E Low
Ronald Feld
James E Brunton
Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital
Canadian Journal of Infectious Diseases
title Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital
title_full Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital
title_fullStr Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital
title_full_unstemmed Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital
title_short Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital
title_sort cotrimoxazole resistant escherichia coli bacteremia in neutropenic patients at a regional oncology hospital
url http://dx.doi.org/10.1155/1992/140845
work_keys_str_mv AT danielbgregson cotrimoxazoleresistantescherichiacolibacteremiainneutropenicpatientsataregionaloncologyhospital
AT annegmatlow cotrimoxazoleresistantescherichiacolibacteremiainneutropenicpatientsataregionaloncologyhospital
AT andrewesimor cotrimoxazoleresistantescherichiacolibacteremiainneutropenicpatientsataregionaloncologyhospital
AT petergtuffnell cotrimoxazoleresistantescherichiacolibacteremiainneutropenicpatientsataregionaloncologyhospital
AT donaldelow cotrimoxazoleresistantescherichiacolibacteremiainneutropenicpatientsataregionaloncologyhospital
AT ronaldfeld cotrimoxazoleresistantescherichiacolibacteremiainneutropenicpatientsataregionaloncologyhospital
AT jamesebrunton cotrimoxazoleresistantescherichiacolibacteremiainneutropenicpatientsataregionaloncologyhospital